Skip to search formSkip to main contentSkip to account menu

HYPOMYELINATION AND CONGENITAL CATARACT

Known as: HLD5, HYPOMYELINATION AND CONGENITAL CATARACT: HCC, LEUKODYSTROPHY, HYPOMYELINATING, 5 
National Institutes of Health

Related topics

Related topics

7 relations
Abnormal pyramidal signsAction TremorAutosomal recessive inheritanceDysarthria

Broader (2)

CataractHereditary Central Nervous System Demyelinating Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non‐interferon‐based treatments
The incidence of hepatocellular carcinoma (HCC) in patients with a history of curatively‐treated HCC is higher than in patients… 
Review
2018
Review
2018
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
ObjectivesTo compare the therapeutic outcomes and safety of radiofrequency (RF) ablation for subcardiac and non-subcardiac… 
2013
2013
Clinical and pathological features and surgical treatment of Budd‐Chiari syndrome‐associated hepatocellular carcinoma
Background Budd‐Chiari syndrome (BCS) is characterized by liver sinusoidal congestion, ischemic liver cell damage, and liver… 
2012
2012
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of hepatocellular carcinoma.
OBJECTIVE The objective of our study was to evaluate the efficacy and safety of percutaneous radiofrequency ablation (RFA) using… 
2008
2008
Differences in Long-term Outcome and Prognostic Factors According to Viral Status in Patients with Hepatocellular Carcinoma Treated by Surgery
Long-term postoperative survival and prognostic factors were examined retrospectively in patients with hepatocellular carcinoma… 
2003
2003
Analysis of Background Factors and Evaluation of a Population at High Risk of Hepatocellular Carcinoma
Objective: We investigated the background clinical factors of patients with hepatocellular carcinoma (HCC) diagnosed at our… 
2002
2002
Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.
AIM To study the relationship between prognosis and pathological characteristics, proliferating cell nuclear antigen labeling… 
2000
2000
Paul Brousse Liver Transplantation: the first 1,500 cases.
During the past 16 years, more than 1,500 liver transplants were performed at Paul Brousse Hospital. The overall patient survival… 
Review
1987
Review
1987
Calcification in hepatocellular carcinoma: not always an indication of fibrolamellar histology.
A distinct pathologic and clinical type of hepatocellular carcinoma (HCC), called fibrolamellar HCC, has been recognized during… 
Review
1987
Review
1987
Surgical Treatment of Subclinical Cases of Hepatocellular Carcinoma
Subclinical cases of hepatocellular carcinoma (subclin-HCC) are arbitrarily defined as those without obvious HCC symptoms and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)